Plain-English translation of NCT05705648 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing medium chain triglyceride oil to see if it can help people who are struggling with brain fog, memory problems, or other thinking difficulties that started or got worse after their COVID-19 infection. About half of the participants will receive the active medication, while the other half will receive a placebo oil that looks and tastes similar but has no active ingredients. The study lasts 5 months, and researchers will track whether the medication helps with the cognitive symptoms people are experiencing.
Many people with long COVID report ongoing problems with concentration, memory, and mental clarity—sometimes called 'brain fog'—but there aren't many proven treatments available. This trial is exploring whether this medication might help reduce these frustrating symptoms and improve quality of life.
You will take 15 milliliters of either the active medication or placebo oil three times per day for 5 months. You'll be randomly assigned to receive either the active treatment or the placebo, so you won't know which one you're getting. Throughout the study, you'll likely have check-in visits or contacts with the research team to monitor how you're doing and report on any changes in your cognitive symptoms.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Canada